Related Experiment Video
Updated: Jan 20, 2026
Enhancing Drug Delivery in Recurrent Glioblastoma with Laser-Induced Hyperthermia
Published on: August 7, 2025
Dantrolene Should Be Readily Available Wherever Malignant Hyperthermia Triggering Drugs Are Stocked
Marilyn Green Larach1, Sheila Riazi, Henry Rosenberg
1The North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States, Department of Anesthesiology, University of Florida College of Medicine, Gainesville, Florida, Malignant Hyperthermia Association of the United States, Sherburne, New York, mlarach@gmail.com Department of Anesthesia and Pain Management, University Health Network, University of Toronto, Toronto, Canada, Board of Directors and Professional Advisory Council, Malignant Hyperthermia Association of the United States, Sherburne, New York Board of Directors and Professional Advisory Council, Malignant Hyperthermia Association of the United States, Sherburne, New York.
No abstract available in PubMed .
Related Concept Videos
Enhancing Drug Delivery in Recurrent Glioblastoma with Laser-Induced Hyperthermia
04:25Local Hyperthermia for Warts Treatment
Magnetic Hyperthermia-Induced Cell Damage in Murine Microglial Cells
08:32Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
06:45In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
06:02Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release

